GREM2 and prostate cancer: Although the effect of GREM2 on cancer-associated fibroblasts in the breast cancer microenvironment is still unknown, exosomal miR-423-5p secreted by cancer-associated fibroblasts in prostate cancer is known to be able to promote chemotherapy resistance by inhibiting GREM2 [55].